Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL)
Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2023-10-29. On CanQuery you can follow the original downloads. Files are available in English and French.
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of "brimonidine or its salts" on the Prescription Drug List (PDL). Note that both the human and veterinary parts of the PDL were revised with the addition of a qualifier.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-10-29
Data overview
- Formats
- HTML
- File languages
- English, French